University takes global action against Malaria in expectant mothers

Mount Kenya University (MKU) is ramping up its research efforts in the fight against malaria, with a specific focus on the disease's impact on pregnant women.

Through an international program, students and postdoctoral researchers will acquire vital research experience in Germany while addressing malaria-related challenges.

“This initiative is part of the ‘Africa Meets Bavaria’ program, which aims to foster a strong research culture among our students and empower them to tackle real-world issues,” stated MKU Vice Chancellor Prof. Deogratius Jaganyi.

The university is collaborating with the Japan International Cooperation Agency (JICA), which has supported the initiative by equipping MKU laboratories and facilitating research opportunities abroad.

“Malaria has long been a challenge in our country, especially for vulnerable populations like expectant mothers. With JICA’s support, our researchers can now delve deeper into the disease—examining immunity, pregnancy-specific responses, and potential vaccine development,” added Prof. Jaganyi.

Leading malaria researcher Dr. Ngara Chome emphasized that the study examines how malaria affects both mothers and their unborn children.

“Our research group is working closely with communities, particularly in Kilifi County and other malaria-endemic coastal regions. We are investigating not only the biological aspects of malaria but also the awareness levels among pregnant women regarding the transmission of malaria to their babies,” said Dr. Chome.

This renewed focus comes as Kenya faces troubling statistics—over 5 million cases of malaria were reported in 2024 alone.

 According to the Ministry of Health, more than 70 percent of the population is still at risk, with malaria contributing to school absenteeism, reduced productivity, and increased household health expenses.

Prof. Jesse Gitaka, a leading researcher at MKU, stated that despite these challenges, Kenya has made notable progress.

“Encouraging research at the student level fosters critical thinking and equips them to address both national and global health challenges. Continuous research is necessary to stay ahead of emerging strains and drug resistance,” said Prof. Gitaka.

Malaria prevalence has dropped from 8 percent in 2015 to 6 percent by 2020, and reported cases decreased from 9.2 million in 2007 to 5.6 million in 2023.

 Outpatient visits due to malaria have fallen from nearly one-third to 16 percent. Prof. Gitaka highlighted the importance of building on this progress.

“Just a few years ago, COVID-19 reminded us how quickly diseases can evolve. The same applies to malaria. Some strains are showing resistance to existing treatments, making our research more urgent,” he said.

The university’s ongoing investments in research infrastructure, including its Directorate of Research and Innovation, reflect its commitment to becoming a global hub for scientific excellence.

“We're not just training future researchers; we're shaping policies and health outcomes. Our vision is to lead in education, research, and innovation that directly benefits our society,” concluded Prof. Jaganyi.